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I968.-Changes in metabolism of an intravexmusly injected tracer dose of 64Cu were measured in Sprague-Dawley rats subjected to copper loading, by addition of cupric acetate to the drinking water, or made copper deficient, by use of a milk-powder diet and copper-free water. In the copperdeficient rats, hepatic copper conservation became evident within the first few weeks on the regimen; biliary excretion of copper and 6"Cu and plasma oxidase and copper levels promptly decreased. Hepatic copper content decreased only slowly. In copper-laden rats, hepatic copper content increased to high levels but release of biliary 6%~ and ceruloplasmin- 6%~ by the liver decreased sharply.
Urinary excretion of copper increased. In these respects, the copper-laden rat superficially simulates patients with Wilson's disease.
ceruloplasmin;
copper-deficiency anemia; isolated perfused rat liver; Wilson's disease T HE NORMAL RAT on our standard Rockland diet contains about 0.5 mg of copper ( 7) . This is maintained by the daily oral intake of ZOO-300 pg of copper, most of which is excreted in the feces; urinary excretion is about 3 pg/day. The fecal copper represents unabsorbed copper and, to a smaller extent, copper that has been absorbed, concentrated by the liver, and excreted into the gut by way of the bile. Biliary copper has been found to be virtually unabsorbable front the gut (8) . A fraction of the hepatic copper is returned to the circulation as ceruloplasmin which perhaps serves as the copper donor for other tissues (3, 9).
The clinical manifestations of copper deficiency and copper toxicity are well known in animals, and sonle biochemical changes have been observed ( 11). In man, deficiency of copper has produced no unequivocal abnormality ( 1). H owever, acute copper toxicity in man (4) and the chronic copper toxicity of Wilson's disease ( 12) are well documented. (9) . Copper in tissues was measured by the arazate method (7) after wet ashing.
Intact rats were kept in metabolic cages for evaluation of fecal and urinary copper excretion.
Rats with biliary fistulas were kept in restraining cages during collections of bile for measurement of stable and radioactive biliary copper. The tracer dose for all rats was 5 ,ug of copper as cupric acetate-s4Cu1 administered intravenously.
Protocols
Isolated liver perfusions were performed by our adaptation ( 10) of the Brauer technique (2). The tracer dose (5 pg) was added to the perfusate. The liver and the blood pump were continuously monitored for radioactivity; blood was sampled hourly and bile was sampled halfhourly or hourly. Radioactivity in the samples was measured in a well-type counter with XaI(T1) crystals. Cu@er-Laden Rats Figure 1 summarizes whole blood hemoglobin, hepatic copper, plasma copper, and plasma oxidase values as a function of time on the high-copper regimen. The hemoglobin concentration was almost invariably within two standard deviations of the mean normal value ( 14.3 g/ 100 ml) in our rat colony. Hepatic copper concentration increased rapidly to levels as much as 20 times the normal value (4.38 pg/g wet weight).
Although plasma copper concentration increased somewhat above the normal level ( 123 pg/lOO ml) in some copper-laden rats, the increase was not commensurate with that of hepatic copper. Plasma oxidase activity increased slightly above normal (54.1 U/ml) in some rats. Studies in rats with Mary jstulas. Bile was collected continuously from control and from copper-laden rats for 5 hr after injection of labeled copper, and then the rats were killed and the 64Cu in the liver, blood, and plasma was measured (Table  1) . Hepatic uptake of Wu was more than double that in the controls, and the blood and plasma levels were about one-fourth of control values. More than half the plasmatic 63Cu was in the form of ceruloplasmin in both the control and the copper-laden rats but, because of the reduced total radioactivity in the latter, the actual amount of ceruloplasmin-Wu was only one-fourth of normal. Studies in intact rats. After injection of the labeled copper, the rats were placed in metabolic cages which effec- tively separated urine from feces. After 48 hr, the 64Cu in blood, liver, and excreta was measured (Table  2)  Labeled ceruloplasmin was not specifically measured because in other studies we have found that within 24 hr at least 95 76 of the plasmatic 64Cu is in the form of ceruloplasmin. The copper-laden rats again showed the exaggerated hepatic uptake and the reduced blood and plasma levels of 64Cu. Although fecal excretion of 64Cu was about normal, urinary excretion was sharply reduced, paralleling the low blood 64Cu level. Table  3 , representing stable copper data on 24-hr samples of urine and feces, shows somewhat different results. The difference is explainable in part by the fact that the 64Cu had been given intravenously.
Copper-laden rats excreted more copper in both urine and feces than did normal rats. Studies in isolated perfused liver. Eight livers from copperladen rats were perfused with blood containing 5 pg of labeled copper. Hepatic uptake was greater than normal (Table 4) . Despite the high hepatic uptake, less than a third of the normal amount of ceruloplasmin-64Cu was in the blood at the end of the 5 hr of perfusion and biliary 64Cu was reduced, paralleling the results in whole rats. months on the regimen (no attempt was made to supplement the diet with iron). The anemia has been attributed to reduced absorption of iron and synthesis of hemoglobin (5, 13), The hepatic copper content of these rats promptly decreased to just below normal but did not become as low as half of normal until the rats had been on the regimen for more than 4 months. In contrast, the plasma copper level and the plasma oxidase activity decreased to half of normal within 20 days.
Studies in rats z&h bilinry $~tuZas. After 65 or more days on the milk-powder regimen, the copper-deficient rats excreted only about 2 % of the normal amount of 64Cu in the bile during the 5 hr after injection of the tracer dose. To determine how rapidly this biliary change occurred, the study shown in Table 5 was conducted on a series of rats during the first 2 weeks of the copperdeficient regimen.
There was an early reduction in the biliary excretion of stable copper (bile flow approximately 1 inl/hr) as well as of 64Cu. Little change occurred in the hepatic uptake of Y2u but the increase in ceruloplasmin-61Cu
in the blood approximately compensated for the reduced biliary excretion so that the total amount of 64Cu processed by the liver (hepatic uptake + ceruloplasmin-""Cu + biliary 64Cu) varied little from normal. The blood level of ceruloplasn~in-64Cu remained increased as long as the rats were studied (Table  1) . Studies ilz intact rats. During the 48 hr after injection of the tracer dose, slightly less than the normal amount of "Y2u (administered intravenously) appeared in the urine and considerably less than normal appeared in the feces (Table  2) . Copper-deficient rats excreted normal amounts of stable copper in the urine but only 1 % of the normal amount in the feces (Table 3) .
Studies in isolated pe$used liver. Several characteristic changes began to be evident within a week on the regimen (Table  4) . Biliary excretion of 64Cu decreased rapidly and remained low to the end of the study (223 days). Uptake of Vu bv the liver was consistently c&ater than normal by thk end of the 1st week on the b regimen.
Unlike the results in whole rats, in which the blood level of ceruloplasmin-64Cu became greater than normal between 1 and 2 weeks, it was not until the rats had been on the milk-powder regimen for about 6 months that their isolated livers consistently released ceruloplasmin64Cu at twice the normal rate.
DTSCUSSION
The continuous administration of a copper salt to rats, in their drinking water, produced an abnormality of copper metabolism superficially resembling that found in Wilson's disease : hepatic copper content was much
